Filter by:
Revita
DTM, 2019
Durable Glycemic and Hepatic Improvements After Duodenal Mucosal Resurfacing in Patients With Type 2 Diabetes
van Baar, et al. presented poster at Diabetes Technology Meeting (DTM). North Bethesda, MD, November 2019.
Revita
AASLD, 2019.
Topline results from REVITA-2: The first randomized, double-blind, sham-controlled, prospective, multicenter study of duodenal mucosal resurfacing (DMR) efficacy, safety, and impact on NASH biomarkers in T2D
Bergman, et al. presented at American Association for the Study of Liver Diseases (AASLD). Boston, MA, November 2019.
Revita
JHEP Reports, November 2019.
Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results
van Baar, et al.
Revita
UEGW, 2019
Duodenal mucosal resurfacing combined with GLP-1 eliminates insulin therapy and improves metabolic health in type 2 diabetes
van Baar, et al. presented at United European Gastroenterology Week 2019 (UEGW). Barcelona, Spain, October 2019.
Revita
Gastrointestinal Endoscopy, October 2019
Duodenal mucosal resurfacing: proof-of-concept, procedural development, and initial implementation in the clinical setting
Haidry, et al.
Revita
ADA, June 2019
Duodenal mucosal resurfacing (DMR) combined with GLP-1 receptor agonism may eliminate insulin treatment while maintaining glycemic control and improving overall metabolic health in type 2 diabetes
Meiring, et al. presented poster at 79th American Diabetes Association Scientific Sessions (ADA). San Francisco, California, USA, June 2019.
Revita
WCITD, April 2019.
Endoscopic Duodenal Mucosal Resurfacing
Hopkins. presented at 4th World Congress on Interventional Therapies for Type 2 Diabetes (WCITD). New York City, NY, USA, April 2019.
Revita
WCITD, 2019
Duodenal Mucosal Resurfacing Improves Glycemic, Lipid and Hepatic Fat Fraction Measures in Type 2 Diabetes
Hopkins, et al. presented poster at 4th World Congress on Interventional Therapies for Type 2 Diabetes (WCITD). New York City, NY, USA, April 2019.
Revita
ObesityWeek, 2019
Diet-Induced Intestinal Mucosal Disequilibrium Contributes to Insulin-Resistant Metabolic Disease
West, et al. presented poster at ObesityWeek 2019. Las Vegas, NV, November 2019.